In 2019, Edwards Lifesciences announced the completion of its acquisition of CAS Medical Systems, Inc. (CASMED), a medical technology company dedicated to noninvasive brain and tissue oxygenation monitoring.
ForeSight Elite tissue oximetry system
Noninvasive monitoring technology
